New Hires to Boost Client Services at Irvine Pharmaceutical Services, Inc.

IRVINE, Calif., Oct. 9 /PRNewswire/ -- Irvine Pharmaceutical Services, Inc., announced today the addition of Muhammad Asif, Ph.D., and Paul Maffuid, Ph.D., to its staff. Dr. Asif was named Director of Analytical Development, and Dr. Maffuid, Senior Vice President of Operations. These highly qualified professionals bring a combined 37 years of pharmaceutical industry experience to the company and to the clients it serves.

With more than 17 years of experience, Dr. Asif has extensive experience supporting the development of pharmaceutical products through his various director and managerial roles at MannKind Corporation, DEY, L.P. (an associate of Merck KGaA), and Wyeth and Fujisawa, USA. His expertise is wide ranging, from analytical method development and validation to extractables/leachables, product characterization studies and preparation of analytical portions of the CMC sections of INDs, NDAs and ANDAs. Dr. Asif holds a Ph.D. in analytical chemistry with an emphasis on HPLC retention mechanism and received his post-doctoral training at the College of Pharmacy, Ohio State University.

Dr. Maffuid's 20 years in the pharmaceutical industry were spent at various notable companies, including Arena Pharmaceuticals, Inc., Magellan Laboratories, Inc., Cabrillo Laboratories, Amylin Pharmaceuticals, Inc., Glaxo research, California Biotechnology and Syntex, Inc. He retains membership in the American Association of Pharmaceutical Scientists and the American Chemical Society, and he has authored several publications. Dr. Maffuid received his Ph.D. and M.S. degree in organic chemistry from the University of California, San Diego, and his B.S. degree in chemistry at St. Michael's College in Winooski, Vermont.

Irvine Pharmaceutical Services welcomes Dr. Maffuid and Dr. Asif as part of the company's ongoing efforts to continually improve its client services through employment of unparalleled professionals. "I am proud to have Dr. Maffuid and Dr. Asif join our staff," said Assad J. Kazeminy, CEO and Founder of Irvine Pharmaceutical Services. "Each brings an impressive depth of knowledge and experience, which I am confident will prove invaluable to our current and future clients."

Since early 2007, Irvine Pharmaceutical Services, Inc., has experienced extensive growth, investing more than a million dollars in upgrading its lab equipment and hiring various respected, often well-known scientists and managers. You can meet the Irvine staff and learn more about the company at the AAPS Annual Meeting, November 16-20, 2008, in Atlanta, GA, booth 1707.

Irvine Pharmaceutical Services, Inc. is a fully integrated services provider that works with pharmaceutical, biotechnology and medical device companies through all phases of research and development. Founded in 1988 and committed to expansion and services that benefit its clients’ priorities directly, Irvine is a fully cGMP compliant pharmaceutical product development and contract testing laboratory located in Irvine, CA. Irvine is able to support clients with analytical method validation, stability testing and storage, aseptic filling, HPLC method development, and pharmaceutical development. Visit www.irvinepharma.com or call (877) 445-6554. To learn more about Irvine's pharmaceutical manufacturer affiliate, Avrio Biopharmaceuticals, visit www.avriobiopharma.com.

Back to news